About Triple Negative Breast Cancer



Research is key in treating triple negative breast cancer. There are three hormone receptors known to fuel most breast cancers: estrogen, progesterone, and HER2. The absence of these receptors in triple negative breast cancer makes it extremely difficult to treat. Traditional hormone therapies will not work; the only recourse is chemotherapy.


Making progress now more than ever. With organizations like the TNBC Foundation, and our own efforts, awareness of the need to do more is growing, funds are being raised for research, and the hope of a cure is stronger than ever.

more to come soon. site in progress.


Know the Facts
Below are facts and figures to help further understand the urgency for a cure.
  • Triple negative breast cancer is an extremely aggressive and fast growing form of breast cancer, which is more likely to recur and more likely to be fatal than other subtypes of breast cancer.
  • A diagnosis of triple negative breast cancer means that the offending tumor is negative for the three receptors known to fuel most breast cancers: estrogen, progesterone and HER2.
  • >Nearly 240,000 women will be diagnosed with breast cancer in the U.S. this year - 36,000 with triple negative breast cancer (15%)
  • Triple negative breast cancer occurs most often in younger women and in women of African American descent.
  • Highly effective treatments such as Herceptin and hormone therapies, such as Tamoxifen and Aromatase inhibitors, are entirely out of reach as treatment options for triple negative patients.
  • There is an urgent need for targeted research and better treatment options for triple negative breast cancer.

  • Source: TNBCFoundation.org.